SCHEMBL5960093

SCHEMBL5960093

Cc1ccc(S(=O)(=O)/N=C/c2ccco2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 4/20 1.00
▸ ALDH1A1 P00352 8/20 0.49
▸ GAA P10253 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MAPT P10636 3/20 0.46
▸ ALOX12 P18054 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ APOBEC3G Q9HC16 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960097 1.00 POLB (1.00) POLBALDH1A1GAALMNAMAPT
SCHEMBL5960062 0.85 POLB (0.74) POLBALDH1A1GAALMNAMAPT
SCHEMBL5960061 0.85 POLB (0.74) POLBALDH1A1GAALMNAMAPT
SCHEMBL7767470 0.82 POLB (0.69) POLBALDH1A1MAPTCTDSP1L3MBTL1
SCHEMBL7767471 0.82 POLB (0.69) POLBALDH1A1MAPTCTDSP1L3MBTL1
SCHEMBL5960042 0.79 POLB (0.65) POLBALDH1A1GAALMNAMAPT
SCHEMBL5960043 0.79 POLB (0.65) POLBALDH1A1GAALMNAMAPT
SCHEMBL6634359 0.78 ALDH1A1 (0.70) POLBALDH1A1GAALMNAMAPT
SCHEMBL6634356 0.78 ALDH1A1 (0.70) POLBALDH1A1GAALMNAMAPT
SCHEMBL12444223 0.76 POLB (0.62) POLBALDH1A1GAALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505718-B2 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-11-29 — — US disclosed
US-9505718-B2 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-11-29 — — US disclosed
US-9505718-B2 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-11-29 — — US disclosed
US-20160031817-A1 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-02-04 — — US disclosed
US-20160031817-A1 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-02-04 — — US disclosed
US-20160031817-A1 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-02-04 — — US disclosed
WO-2014142761-A1 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-09-18 — — WO disclosed
WO-2014142761-A1 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-09-18 — — WO disclosed
US-8815935-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-08-26 — — US disclosed
US-20130102639-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-04-25 — — US disclosed
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-21 — — US disclosed
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-21 — — US disclosed
WO-2007111948-A2 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-10-04 — — WO disclosed
US-7049468-B2 Modulators of Rho C activity ICONIX PHARMACEUTICALS, INC. (US) 2006-05-23 — — US disclosed
EP-1453470-A4 MODULATORS OF RHO C ACTIVITY ICONIX PHARM INC (US) 2006-05-17 — — EP disclosed
EP-1453470-A1 MODULATORS OF RHO C ACTIVITY Iconix Pharmaceuticals, Inc. (US) 2004-09-08 — — EP disclosed
US-20030171341-A1 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1: ENTELOS HOLDING CORP. 2003-09-11 — — US disclosed
WO-2003043578-A2 MODULATORS OF RHO C ACTIVITY ICONIX PHARMACEUTICALS, INC. (US) 2003-05-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171341-A1 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1: RHOC, RHOA, ROCK1 POLB 2202/4885ALDH1A1 1730/4885GAA 2156/4885
US-20130102639-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES RABGGTA, FNTA, RABGGTB POLB 3212/4885ALDH1A1 2160/4885GAA 375/4885
US-20160031817-A1 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS TACR1, NPSR1, TACR2 POLB 4666/4885ALDH1A1 1229/4885GAA 3860/4885
US-20110178138-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES RABGGTA, FNTA, RABGGTB POLB 3212/4885ALDH1A1 2160/4885GAA 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback